SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Lecanemab CSF Substudy Findings Presented at CTAD 2026

Lecanemab showed favorable clinical assessment scores at 18 months, including among indiv

BIIB

Related stories